Human cytomegalovirus (HCMV) is a ubiquitous beta-herpesvirus that infects from 60% to nearly 80% of the human population worldwide and, although rarely, causes serious multi-organ infections, such as pneumonia, gastrointestinal diseases and retinitis, which can be fatal in immunosuppressed patients. Additionally, congenital HCMV is associated with neurodevelopmental defects including hearing loss and mental deficits.
To date, there are no vaccines available to prevent HCMV infections, and no drugs have been approved for the treatment of congenital infections. In addition, the drugs currently in use in adults have low bioavailability, non-negligible toxicity, limited efficacy and are subject to drug resistance.
This invention relates to the novel use of clinically approved antifungal compounds, such as posaconazole and isavuconazole, as antivirals to treat HCMV associated infections.


Lead Optimization/Preclinical






Download the brochure

  • Use of small molecules to rescue folding defective proteins

    The use of CFTR (cystic fibrosis transmembrane conductance regulator) correctors for the treatment of rare and devastating genetic muscular diseases, namely sarcoglycanopathies and Brody myopathy, is the object of this invention. Sarcoglycanopathies and Brody myopathy are rare inherited striated muscle[...]

  • Novel treatment to mitigate the Ectrodactyly-Ectodermal dysplasia- Clefting (EEC) associated blindness

    The Ectrodactyly-Ectodermal dysplasia-Clefting (EEC) syndrome is a rare genetic disorder due to mutations in the p63 gene and characterized by limb defects, orofacial clefting, ectodermal dysplasia, and ocular surface defects that lead to the loss of vision. Currently no specific[...]

  • SerpinB3 inhibitor for tumor treatment

    Expression of SerpinB3, a member of serine-protease inhibitor family, is associated with the carcinogenesis process as it determines resistance to apoptosis, induces cell proliferation and greater cell invasiveness. Furthermore, it leads to impaired immune surveillance and reduced chemosensitivity. Recent studies[...]

Subscribe to newsletter

Follow the activities promoted by UniSMART Foundation